Lifevantage Corporation’s shares fell 10.2% in after-hours trading on Thursday after the company reported fourth-quarter and full-fiscal-year 2026 results that missed analyst expectations.
The stock, which closed at $6.45 in regular trading, dropped to $5.79 in extended hours, marking a decline of 2.42% for the day. The company’s 52-week range stands at $3.90 to $14.28.
Fourth-quarter revenue totaled $43.7 million, a 25.2% decrease from the prior-year period. Net income per diluted share fell to $0.11 from $0.26 in the same quarter last year. Lifevantage’s revenue missed analyst estimates by 8.5%, while earnings per share missed by 35%.
For the full fiscal year 2026, Lifevantage’s financial performance reflected broader challenges in the personal products sector. Revenue declined 25.2% year-over-year, and the company projected an average annual revenue decline of 5.4% over the next three years. This compares with a projected 3.7% annual growth rate for the broader U.S. personal products industry.
Lifevantage appointed Terrence Moorehead as CEO in early August 2026, following the release of its fiscal Q4 results.
Institutional investor activity in the most recent quarter showed mixed sentiment. While 39 institutional investors increased their positions, 68 reduced holdings. BlackRock sold over 501,000 shares, a 65.1% reduction in its stake, while Geode Capital Management trimmed its position by 53.7%.
On the day of the drop, major U.S. equity benchmarks showed limited movement, with the S&P 500 down 0.1% and the Nasdaq slipping 0.2%.
